|1.||Grobosch, T: 1 article (11/2008)|
|2.||Lampe, D: 1 article (11/2008)|
|3.||Martens, F: 1 article (11/2008)|
|4.||Binscheck, T: 1 article (11/2008)|
|5.||Saponjic, J: 1 article (09/2004)|
|6.||Pavlovic, S: 1 article (09/2004)|
|7.||Radulovacki, M: 1 article (09/2004)|
|8.||Carley, D W: 1 article (09/2004)|
|9.||Malis, M: 1 article (09/2004)|
|10.||Knezevic, N: 1 article (09/2004)|
|1.||Hypotension (Low Blood Pressure)
12/01/1980 - "Cryptenamine, on the other hand, potentiated nitroprusside-induced hypotension, markedly diminished increases in heart rate, and eliminated increases in myocardial contractility, rate-pressure product, and left ventricular work. "
07/15/1990 - "In a rat model of severe hypotension and respiratory depression induced by step-wise bleeding, protoveratrines cause a prompt and sustained improvement of cardiovascular and respiratory functions, both in anesthetized and in conscious animals, seemingly through a magnification of the reflex response originated by the chemoreceptors of aortic and carotid bodies. "
03/01/1986 - "Cryptenamine (5 micrograms/kg) produced only hypotension and bradycardia (P less than 0.05) whereas Leu5-ENK (35 micrograms/kg) produced only hypertension and tachycardia (P less than 0.05). "
|2.||Ganglion Cysts (Ganglion)
|3.||Hypertension (High Blood Pressure)
09/01/1966 - "Cryptenamine-based mixtures for chronic therapy of benign arterial hypertension."
04/01/1965 - "[Cryptenamine: alkaloid of Veratrum viride, for control of angiospasm in eclamptogenic hypertension]."
06/01/1958 - "The management of moderately severe hypertension with cryptenamine and rauwolfia; observations in patients treated for up to two years."
09/14/1957 - "Protoveratrine A in treatment of hypertension."
12/20/1956 - "A comparison between protoveratrine A and protoveratrine B orally in arterial hypertension; a therapeutically important difference in activity."
09/01/1957 - "Cryptenamine and the toxemias of pregnancy."
09/01/1955 - "Cryptenamine and cerebral function; the effects of cryptenamine (unitensen) on cerebral circulation and metabolism in toxemia of pregnancy."
10/01/1954 - "Continuing vasodilator infusion therapy; utilization of a blend of 1-hydrazinophthalazine (apresoline) and cryptenamine (unitensen) in toxemia of pregnancy."
05/01/1980 - "Protoveratrine-A (PV-A, 0.1 mg/kg), a veratrum alkaloid, also induced retching in mice and vomiting in pigeons, while apomorphine (2 mg/kg) produced neither retching in mice nor vomiting in pigeons though it induced feeding in pigeons. "
02/01/1989 - "However, zacopride was not effective in inhibiting emesis due to either apomorphine, copper sulphate, protoveratrine A, histamine, or pilocarpine. "
|1.||Nitroprusside (Sodium Nitroprusside)
|2.||Cholinergic Agents (Cholinergics)
|8.||Serotonin (5 Hydroxytryptamine)
|1.||Cardiopulmonary Bypass (Heart-Lung Bypass)